GSK urges FDA to tighten regulation of dietary supplements

06/30/2008 | Star-Ledger (Newark, N.J.), The

GlaxoSmithKline has filed a petition asking the FDA to require makers of weight-loss supplements to conduct premarket testing for safety or efficacy and obtain regulatory approval for their products. If approved, the proposed changes could help Glaxo fend off competition for over-the-counter Alli but would also "make it illegal to market dietary supplements for weight loss," said Michael McGuffin, president of the American Herbal Products Association.

View Full Article in:

Star-Ledger (Newark, N.J.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID